New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 25, 2014
08:08 EDTRDHLRedHill Biopharma reports Q4 EPS (5c), one estimate (50c)
Reports Q4 revenue $1K vs. $4K a year ago. Cash Balance as of December 31, 2013 was approximately $12.1M, a decrease of $6.3M, or approximately 34%, compared to December 31, 2012 and a decrease of $1.6M, approximately 12%, compared to September 30, 2013.
News For RDHL From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
July 6, 2015
07:04 EDTRDHLRedHill Biopharma receives authorization in Australia, New Zealand for study
Subscribe for More Information
July 1, 2015
07:09 EDTRDHLRedHill Biopharma receives notice of allowance for two U.S. patents for RHB-104
RedHill Biopharma announced that it has received two notices of allowance from the United States Patent and Trademark Office regarding its patent application numbers 13/722,395 and 14/271,758 covering RHB-104. RHB-104 is a proprietary and potentially groundbreaking antibiotic combination therapy in oral capsule formulation, with potent intracellular, anti-mycobacterial and anti-inflammatory properties, currently undergoing a first Phase III study for Crohn's disease and a Phase IIa study for multiple sclerosis.
June 29, 2015
07:08 EDTRDHLRedHill Biopharma initiates Phase I/II study of ABC294640
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use